GlucoBoost - Glucose Gel - Pack of 3

Product Information

Rapid correction of hypoosmotic hyponatraemia is potentially dangerous (risk of serious neurologic complications). Dosage, rate, and duration of administration should be determined by a physician experienced in paediatric intravenous fluid therapy. Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme. Pulmonary vascular precipitates have been reported in patients receiving parenteral nutrition. In some cases, fatal outcomes have occurred. Excessive addition of calcium and phosphate increases the risk of the formation of calcium phosphate precipitates. Precipitates have been reported even in the absence of phosphate salt in the solution.

Hypoglycaemia in the newborn can cause prolonged seizures, coma and brain damage. Hyperglycaemia has been associated with intraventricular haemorrhage, late onset bacterial and fungal infection, retinopathy of prematurity, necrotizing enterocolitits, bronchopulmonary dysplasia, prolonged length of hospital stay, and death. The product should be inspected visually for particulate matter and discoloration after admixing and prior to administration. Do not administer unless the solution is clear and the seal is intact. When Glucose 40% w/v is used in conjunction with amino acids, the rate of administration of glucose should not exceed 1g/kg/hour for optimal protein anabolism. If > 2.6 mmol/l resume frequent, 3 hly, feeding of at least 10ml/kg/feed and monitor Glc before each feed A late preterm infant who is at risk of hypoglycaemia should be screened with regular monitoring of the capillary glucose concentrations.Snap the lid off the tube of gel and squeeze gel into the child’s lower cheek whilst at the same time gently but firmly massaging the outside of the cheek. It is this action that stimulates partial absorption of the Glucogel. DO NOT place gel on your own finger to rub inside your child’s mouth.

Once blood glucose level if 4mmol/l or above given 10-15g of slow acting carbohydrate (or their normal meal if it is a mealtime) to maintain the blood glucose level If the baby has an ongoing requirement of ≥120 ml/kg/day of milk / 10% glucose to maintain normoglycaemia, refer to the guideline for refractory hypoglycaemia Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers. Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before the administration of the fluid from the secondary container is completed. overhydration/hypervolemia and, for example, congested states, including pulmonary congestion and oedema.A gradual increase of flow rate should be considered when starting administration of glucose-containing products. Notify Paediatrician immediately for all babies who are symptomatic or whose blood Glucose is <1.0mmol/l GlucoBoost Glucose Gel from Ennogen Healthcare is a 40% Glucose Oral Gel that is widely used in the NHS. The occurrence of septic complications can be decreased with heightened emphasis on aseptic technique in catheter placement, maintenance, as well as aseptic technique in nutritional formula preparation. Hepatic failure, Hepatic cirrhosis, Hepatic fibrosis, Cholestasis, Hepatic steatosis, Blood bilirubin increased, Hepatic enzyme increased, Cholecystitis, Cholelithiasis